Clinical Trial Results:
A phase III, randomized, double-blind, active-controlled, equivalence clinical trial to investigate the efficacy and safety of a single injection of 100 µg Org 36286 (corifollitropin alfa) to induce multifollicular development for controlled ovarian stimulation (COS) using daily recombinant FSH (recFSH) as a reference
Summary
|
|
EudraCT number |
2006-003811-36 |
Trial protocol |
SE AT DK CZ FR |
Global completion date |
15 Nov 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v3(current) |
This version publication date |
27 Dec 2018
|
First version publication date |
01 May 2016
|
Other versions |
v1 , v2 |
Version creation reason |
|
Summary report(s) |
EudraCT Summary Results for P05690 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.